Although it has been amply demonstrated that, in breast cancer, antiestrogens targeting ERα are highly effective, the role of estrogen in gynecological cancers is thought to be of less importance due to the lack of clear efficacy of antiestrogens [110]. This evidence concerns the gene ESR1 and breast cancer.